Correlation Between Crispr Therapeutics and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Elevation Oncology, you can compare the effects of market volatilities on Crispr Therapeutics and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Elevation Oncology.
Diversification Opportunities for Crispr Therapeutics and Elevation Oncology
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Crispr and Elevation is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Elevation Oncology go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Elevation Oncology
Given the investment horizon of 90 days Crispr Therapeutics is expected to generate 8.7 times less return on investment than Elevation Oncology. But when comparing it to its historical volatility, Crispr Therapeutics AG is 3.75 times less risky than Elevation Oncology. It trades about 0.07 of its potential returns per unit of risk. Elevation Oncology is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 57.00 in Elevation Oncology on October 23, 2024 and sell it today you would earn a total of 12.13 from holding Elevation Oncology or generate 21.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Elevation Oncology
Performance |
| Timeline |
| Crispr Therapeutics |
| Elevation Oncology |
Crispr Therapeutics and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Elevation Oncology
The main advantage of trading using opposite Crispr Therapeutics and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |